Advisory Services Network’s BioNTech BNTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-100
Closed -$8.89K 2470
2026
Q1
$8.89K Buy
+100
New +$10.3K ﹤0.01% 3615
2025
Q4
Sell
-100
Closed -$9.86K 2104
2025
Q3
$9.86K Buy
+100
New +$10.7K ﹤0.01% 3291
2024
Q1
Sell
-499
Closed -$52.7K 1728
2023
Q4
$52.7K Buy
+499
New +$50.3K ﹤0.01% 1982
2023
Q2
Sell
-319
Closed -$39.8K 1714
2023
Q1
$39.8K Buy
319
+9
+3% +$1.24K ﹤0.01% 2149
2022
Q4
$46.6K Buy
+310
New +$47.7K ﹤0.01% 2006
2021
Q3
Sell
-209
Closed -$47K 1624
2021
Q2
$47K Buy
+209
New +$39.4K ﹤0.01% 2034

Other funds holding BNTX

Advisory Services Network's BNTX Position: Q2 2026 in Review

Advisory Services Network sold out of BioNTech (BNTX) in Q2 2026, closing a stake of 100 shares — an estimated $8.89K sold.

Advisory Services Network first reported a position in BNTX in Q2 2021 and held it in 6 quarters. The position peaked at $52.7K in Q4 2023. 283 funds tracked by Wall St. Rank hold BNTX as of Q2 2026.

  • Advisory Services Network reported no remaining BioNTech position as of Q2 2026 after selling out during the quarter.
  • Advisory Services Network sold 100 BioNTech shares in Q2 2026, an estimated $8.89K.
  • Advisory Services Network first reported a position in BioNTech in Q2 2021 and held it in 6 quarters.
  • Advisory Services Network's BioNTech position peaked at $52.7K in Q4 2023.
  • 283 funds tracked by Wall St. Rank held BioNTech as of Q2 2026.

Based on Advisory Services Network's 13F filing for Q2 2026, filed 12 Aug 2026.